ArticleThe Journal of dermatology2026
Analysis of Phosphorylated MEK1 Expression Pattern in Cutaneous Dilated Vessels of Capillary Malformations.
Article in The Journal of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The mechanism of capillary malformation (CM) is thought to be the abnormal dilation of capillaries as a result of activation of the RAS-RAF-MEK-ERK pathway due to GNAQ/GNA11 gene mutations. However, no prior studies have actually demonstrated phosphorylation of MEK in CM. CMs were classified into three types according to clinical and histopathological findings: Flat, hypertrophic, and nodular. Comparison of the expression pattern of phosphorylated MEK1 (p-MEK1) in these three types of CMs revealed that p-MEK1 staining was positive in dilated capillaries in the upper dermis of the flat CMs. Double staining was performed to determine which cells of CM expressed p-MEK1: CD34 and p-MEK1 showed partial co-localization, demonstrating that p-MEK1 is expressed in the vascular endothelial cells. Both p-MEK1-positive and p-MEK1-negative vessels were observed in dilated vessels of CM. In addition, p-MEK1-positive vessels may be present deeper than anticipated. JNK and ERK were also phosphorylated in the dilated vessels. Furthermore, in contrast to the flat type and hypertrophic type of CM, the nodular type showed no p-MEK1 expression in its proliferated capillaries, supporting the notion that nodular CMs arise via a distinct mechanism. Taken together, our results indicated that visualization of affected vessels of CM using p-MEK1 immunostaining is useful not only for diagnosis but also for understanding the pathogenesis of CM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.